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Metaplasia in Barrett’s esophagus (BE) is characterized by the transition of squamous 
epithelium into intestinal-type columnar epithelium. The immune response in BE shares 
many similarities with the response found in the gut, which is different from the response 
found in a normal-looking esophagus. Here, we investigated the role of the genes asso-
ciated with the retinoic acid (RA) pathway in BE, as RA is important not only in shaping 
the gut’s immune response but also in the induction of metaplasia in vitro. mRNA was 
isolated from esophageal and duodenal biopsies from BE (n = 14), reflux esophagitis 
patients (n = 9), and controls (n = 12). cDNA was made and qPCR was performed. 
The expression of RALDH1, CYP26A1, MAdCAM1 were similar for both the BE and 
duodenum, but different when compared to squamous esophageal epithelium. BE was 
characterized by a higher expression of RALDH2 and FOXP3, compared to the duode-
num. In BE, RALDH2 correlated with expression of the myeloid dendritic cell-specific 
genes: CD11c and CD1c. Also, RALDH2 expression correlated with RAR-β and FOXP3. 
Hierarchical clustering on the expression of multiple relevant genes demonstrated that 
BE, duodenum, and SQ tissues are clustered as three different groups. The differen-
tial expression of RA-specific genes and dendritic cell (DC)-subsets indicates that BE 
resembles duodenal tissue. The higher expression of RALDH2 and FOXP3 in BE points 
at a mechanism associated with a possible anti-inflammatory microenvironment. This 
aberrant immune regulation might contribute to the altered tissue and immune responses 
found in BE.
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inTrODUcTiOn
Barrett’s esophagus (BE) is characterized by a metaplasia from a multi-layered squamous epithelium 
into an intestinal-like, single-layered cylinder epithelium (1). Patients with BE have an incidence rate 
of around 1 in 200 per patient-year to develop esophageal adenocarcinoma (EAC) (1). The incidence 
of EAC continues to increase, and it is currently the fastest rising malignancy in the Western World (2).
Abbreviations: mDC, myeloid dendritic cell.
TaBle 1 | Patient characteristics.
Barrett’s esophagus 
patients
controls reflux 
esophagitis
Number of patients 14 12 9
Mean age (±SD) 53 ± 12 58 ± 14 59 ± 14
Gender (% males) 50 25 67
Presence of low  
grade dysplasia
7% – –
PPI use (%) 100 42 89
Hiatal Hernia (%) 86 8 22
TaBle 2 | Antibodies for FACS staining.
mAb CD3 (T-cell)-FITC clone sk7, 1:20 BD Biosciences,  
Bedford, MA, USA
CD3-PE clone sk7, 1:20 BD Biosciences
CD8 (cytotoxic T-cell) clone SK1, 1:100 BD Biosciences
CD8-PerCP clone SK1, 1:20 BD Biosciences
CD4 (T-helper cell)-PerCP clone L200, 1:20 BD Pharmingen,  
San Diego, CA, USA
CD49d (α4-integrin)-FITC clone BU49, 1:20 EuroBiosciences,  
Friesoythe, Germany
β7 (integrin)-PerCP/Cy5.5 clone FIB27, 1:25 BioLegend, CA, USA
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Recently, it was shown that the immune cells found in BE 
and duodenal tissues are characterized by the presence of very 
similar T-cell phenotypes and a comparable expression of adhe-
sion molecules, which is different from healthy esophageal tissue 
(3). However, little is known about the underlying mechanism 
mediating this aberrant immune response in BE tissue. Retinoic 
acid (RA) plays a key role in immune cell differentiation and an 
important role in metaplasia and oncogenesis by inducing both 
pro-oncogenic and anti-oncogenic effects (4–6). If expression lev-
els of RA-pathway-specific genes are similar in BE and duodenal 
tissue, this would lead to a similar immune microenvironment.
Retinoic acid also plays an important role in the expression 
of integrins and chemokine receptors in intestinal tissue, thereby 
steering homing of leukocytes to their homeostatic tissue sites 
(5). Aberrant RA-metabolism in BE might, therefore, redirect 
leukocytes to BE tissue that normally would home exclusively 
to gut tissue. Chang et al. have shown that there are enhanced 
levels of RA in BE tissue, but the relation between RA and tissue 
immune response was not investigated. As such, the primary cel-
lular source of RA and its influence on development of Barrett’s 
adenocarcinoma remain unknown (7).
Chang’s and others findings were supported by experiments 
in vitro showing that RA was able to induce intestinal metaplasia 
(IM) in squamous esophageal tissue (7, 8). The current study was 
designed to determine the presence of enzymes that are important 
in RA synthesis in esophageal tissues from controls and BE patients 
(9, 10). As dendritic cells (DCs) are an important source of RA, the 
expression of various DC-markers was also measured (11).
Aim of the study was to investigate the expression of RA-related 
and DC-specific genes in duodenal and esophageal tissues from 
controls and BE patients.
MaTerials anD MeThODs
characteristics of Patients and controls
Thirty five patients and controls were included in our study (see 
Table 1). Of these, 14 patients had BE, as defined by the presence 
of specialized IM containing goblet cells in at least one biopsy. 
Tissue biopsies were taken from BE epithelium (n = 10), duodenal 
tissue (n = 12), and squamous esophageal tissue (n = 10). Nine 
patients had reflux esophagitis (RE), which was characterized by 
gastroesophageal reflux complaints and fulfilled the endoscopic 
diagnostic criteria according to the Los Angeles classification 
(12). From RE patients, tissue was taken from the inflamed and 
non-inflamed squamous esophageal epithelium. 12 unrelated, 
healthy controls were selected from patients who underwent 
upper endoscopy for upper gastrointestinal symptoms other than 
gastroesophageal reflux disease (GERD), and had no previous 
history of GERD or immune-associated disorders, such as celiac 
disease, and no history of duodenal diseases. Symptoms of both 
controls and RE/BE patients were evaluated by a standardized 
questionnaire, which needed to be negative for GERD symptoms 
(13). From five controls duodenal biopsies were taken, which 
were used for mRNA isolation. Demographic data of patients and 
controls are summarized in Table 1. Figure S1B in Supplementary 
Material shows immunohistochemical staining of BE, SQ, and 
DUO biopsies, used in this study for mRNA isolation.
The Medical Ethical Committee of the University Medical 
Center Utrecht approved this study, and written informed con-
sent was obtained from all patients and controls.
isolation of Peripheral Blood Mononuclear 
cells (PBMcs) and expansion of 
lymphocytes
Blood was obtained from healthy volunteers at the donor service 
of the Utrecht University Medical Center and anticoagulated with 
0.4% (w/v) trisodium citrate (pH 7.4). PBMCs were isolated as 
described in the literature (14).
Ex Vivo expansion of T-cells
Expansion of T-cells from biopsies was performed essentially 
using methods described in the literature (15).
analysis by Flow cytometry
The immunophenotyping of lymphocytes was performed on 
collagenated biopsies and on day 14 of the ex vivo expansion (3) 
(Figure S1A in Supplementary Material).
Cells (0.5 × 103–105) were washed with PBS2+ and subsequently 
incubated for 30  min on ice with directly labeled antibodies 
(Table  2) according to manufacturer’s instructions. After wash-
ing with PBS2+, the cells were analyzed by FACS essentially as 
described in the literature (3). Cell populations positive for CD4, 
CD8, CD49d (α4), and β7 were identified by testing the specific 
antibodies together with the appropriate isotype control on 
PBMCs. Isotype controls could not be included in the ex vivo cul-
tured cells’ experiments due to the small number of cells available.
rna isolation and cDna synthesis
RNA was purified from esophageal biopsies using the RNeasy 
Mini Kit (Qiagen, Valencia, CA, USA), according to the 
FigUre 1 | (a) Similar expression of MAdCAM1 Barrett’s esophagus (BE) and duodenal tissues. (B) Expression of CCL25 in BE is intermediate between squamous 
esophageal tissue and duodenal tissue. Real-time (RT) PCR was performed on a total of: reflux esophagitis (RE) biopsies (INFL RE, n = 9), non-inflamed squamous 
esophageal epithelium from RE patients (SQ RE, n = 9), squamous esophageal epithelium from controls (n = 12), squamous esophageal epithelium from BE 
patients (SQ BE, n = 10), BE biopsies from BE patients (BE, n = 11), duodenal biopsies from BE patients (DUO BE, n = 10), and duodenal biopsies from controls 
(DUO C, n = 5). Expression of MAdCAM1, corrected for GAPDH, 2−ΔCT ± SEM, is represented on the y-axis in (a). Expression of CCL25 corrected for GAPDH, 
2−ΔCT ± SEM is represented on the y-axis in (B). The Kruskal–Wallis test was used to compare all the groups (p < 0.0001), p-values from comparing individual 
groups were obtained by using Mann–Whitney U test in case of individual groups and Wilcoxon signed rank test for different tissue types from the same patient. 
Adjustment for multiple comparison was conducted by Benjamini–Yekutieli method.
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manufacturer’s instructions. For cDNA synthesis, 1 µg total RNA 
was transcribed into cDNA with the cDNA transcription reagents 
(Bio-Rad, Hercules, CA, USA) using oligo (dT) and random 
primers according to manufacturer’s instructions.
real-Time (rT) Pcr: cDna analysis
Amplification and RT detection of PCR products with SYBR 
green was performed using the MyiQ RT PCR detection 
system (Bio-Rad, Hercules, CA, USA) under the following 
FigUre 2 | Similar expression of VCAM-1 in Barrett’s esophagus (BE) and 
duodenal tissues. Figure 2 represents expression of VCAM-1 on the y-axis, 
corrected for GAPDH, 2−ΔCT ± SEM. The Kruskal–Wallis test was used to 
compare the groups. The Kruskal–Wallis test was used to compare all the 
groups (p < 0.0001), p-values from comparing individual groups were obtained 
by using Mann–Whitney U test in case of individual groups and Wilcoxon 
signed rank test for different tissue types from the same patient. Adjustment for 
multiple comparison was conducted by Benjamini–Yekutieli method.
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conditions: 3  min at 95°C and 40 cycles of 30  s at 95°C, 30  s 
at 60°C, and 30  s at 72°C. The results represent the relative 
quantity of mRNA levels normalized to the housekeeping gene 
GAPDH (glyceraldehyde-3-fosfaat dehydrogenase) and plot-
ted as fold change. The expression level of a gene in a given 
sample was represented as 2−ΔCT, where ΔCT = [CT(experimental)] −  
[CT(housekeeping)]. PCR assays were performed in duplicate. Primers 
excluding those described below, were purchased from Sigma 
Aldrich, St. Louis, MO, USA (Table S1 in Supplementary Material). 
Primers for RALDH1 (Aldh1A1), RALDH2 (Aldh1A2) (retinal-
dehyde dehydrogenases 1,2), RAR-β (RA receptor-β) ubiquitin 
C, hprt (hypoxanthine-guanine-fosforibosyl-transferase), and 
GAPDH (Isogen Life Science, De Meern, The Netherlands; 
Invitrogen) were designed across exon–intron boundaries using 
Primer Express software (PE Applied Biosystems, Foster City, 
CA, USA). RT PCR for RALDH1, 2, and RAR-β was performed 
on an ABI Prism 7900HT sequence detection system (PE Applied 
Biosystems). The total volume of the reaction mixture was 10 µl, 
containing cDNA, 300 nM each primer, and SYBR Green Master 
Mix (PE Applied Biosystems). The comparative CT method (ΔCT) 
was used to assess relative changes in mRNA levels between 
samples.
statistical analysis
All continuous variables were analyzed for significance with 
one-way analysis of variance non-parametric test, using the 
Kruskal–Wallis test to compare the groups: BE tissue (BE), duo-
denum of BE patients (DUO BE), duodenum of controls (DUO 
C), inflamed (INFL RE) and non-inflamed squamous esophageal 
tissue of RE patients (SQ RE), BE patients (SQ BE), and controls 
(SQ C). To identify transcripts that were differentially expressed 
between various tissue types in BE, patients, RE patients, and 
controls, we used analysis of variance for non-parametric data 
(Kruskal–Wallis test) with Benjamini–Yekutieli correction for 
multiple comparisons, as provided by R software (R Foundation 
for Statistical Computing, Vienna, Austria), with False 
Discovery Rate (FDR) set to 0.05 (16). p-values for comparing 
the individual groups were obtained by using Mann–Whitney 
U test when comparing independent groups and Wilcoxon 
signed rank test was used when comparing different tissue types 
in the same patients (e.g., duodenum tissue and Barrett tissue 
from BE patients).
Spearman’s correlation coefficients (data were non-paramet-
ric) were performed to explore association in mRNA expression 
of RALDH2 with DC-specific markers in BE. Also, correlation 
analysis was performed on DC-markers in inflamed tissue from 
RE patients (INFL RE) and duodenal tissues. Correlations were 
corrected for multiple testing by Benjamini–Yekutiele method, 
with FDR set to 0.05. Expression of FOXP3 was not corrected for 
multiple comparison, because the decision to measure FOXP3 
expression was made as a consequence of the differential expres-
sion of RA-related genes.
A two-sided p-value < 0.05 was considered to be statistically 
significant. Statistical analyses were conducted using GraphPad 
Prism 5 (GraphPad Software, La Jolla, CA, USA), SPSS (Statistical 
Package for Social Sciences, version 22; SPSS Inc., Chicago, IL, 
USA), and R program.
hierarchical clustering
Hierarchical clustering was conducted using the program 
OmniViz®, version 6.1.2 (BioWisdom Ltd., Maynard, MA, USA).
resUlTs
similar mrna expression of adhesion 
Molecules in Duodenum and Be
We determined the expression of mRNA of the endothelial inte-
grin and chemokine receptor ligands MAdCAM1 (mucosal vas-
cular addressin cell adhesion molecule 1), VCAM-1 (vascular cell 
adhesion protein-1), and the intestinal homing chemokine CCL25 
(Chemokine (C-C motif) ligand 25/TECK) (17). Expression of 
MAdCAM1 was similarly low in squamous esophageal epithelium 
(SQ) obtained from the different patient groups (RE patients, BE 
patients, and controls; Figure 1A). Expression of MAdCAM1 in 
SQ RE, SQ C, and inflamed tissue from RE (INFL RE) was signifi-
cantly lower compared to the expression of MAdCAM1 in mRNA 
taken from biopsies of both the duodenum and BE (Figure 1A). 
Expression of MAdCAM1 in SQ BE was also significantly lower 
compared to BE and SQ C (Figure 1A). However, expression of 
MAdCAM1 in SQ BE tended to be lower compared to DUO BE, 
but the difference did not reach statistical significance (p = 0.09) 
(Figure 1A). Expression of CCL25 was low in SQ for all three 
groups (RE patients, BE patients, and controls). The expression 
of CCL25 was markedly enhanced in duodenal tissue of controls 
and BE patients, which was significantly higher compared to all 
SQ tissues (Figure 1B) (18). The expression of CCL25 in BE was 
significantly lower compared to both duodenal tissues, and was 
significantly higher compared to squamous esophageal tissues 
in RE patients and controls (Figure  1B). It was, however, not-
significantly higher compared to SQ BE (Figure 1B).
FigUre 5 | High expression of RALDH2 and FOXP3 in Barrett’s esophagus 
(BE) tissue. Panel (a) depicts expression of RALDH2 by real-time (RT)-PCR 
performed on a total of: inflamed reflux esophagitis (RE) biopsies (INFL RE, 
n = 9), non-inflamed squamous esophageal epithelium from RE patients (SQ 
RE, n = 9), squamous esophageal epithelium from controls (SQ C. n = 12), 
squamous esophageal epithelium from BE patients (SQ BE, n = 10), BE 
biopsies (BE, n = 11), duodenal biopsies from BE patients (DUO BE, n = 10), 
and duodenal biopsies from controls (DUO C, n = 5). Panel (B) depicts 
expression of FOXP3 by RT-PCR performed on a total of: inflamed RE biopsies 
(INFL RE, n = 6), non-inflamed squamous esophageal epithelium from RE 
patients (SQ RE, n = 7), squamous esophageal epithelium from controls (SQ 
C, n = 12), squamous esophageal epithelium from BE patients (SQ BE, n = 7), 
BE biopsies (BE, n = 8), duodenal biopsies from BE patients (DUO BE, n = 5), 
and duodenal biopsies from controls (DUO C, n = 5). In panels (a,B) data 
were analyzed, using the Kruskal–Wallis test (RALDH2: p < 0.0001, FOXP3: 
p < 0.0001). RALDH2 expression and FOXP3 expression was corrected was 
corrected for GAPDH, 2−ΔCT ± SEM. p-values from comparing individual 
groups were obtained by using Mann–Whitney U test in case of individual 
groups, and Wilcoxon signed rank test for different tissue types from the same 
patient. Adjustment for multiple comparison was conducted by Benjamini–
Yekutieli method. In panel (c), correlation and linear regression (red line) 
between expression of FOXP3 and RALDH2 in BE biopsies are shown, R 
(correlation coefficient) = 0.82, p = 0.03. The Spearman correlation was 
conducted as there was no normal distribution of data.
FigUre 4 | High expression of CYP26A1 in inflamed reflux esophagitis 
tissue. Figure depicts expression of CYP26A1 by real-time-PCR, corrected 
for GAPDH, 2−ΔCT ± SEM (p = 0.0005). p-values from comparing individual 
groups were obtained by using Mann–Whitney U test in case of individual 
groups and Wilcoxon signed rank test for different tissue types from the 
same patient. Adjustment for multiple comparison was conducted by 
Benjamini–Yekutieli method.
FigUre 3 | Low expression of RALDH1 in squamous esophageal tissues 
and similarly high expression of RALDH1 in Barrett’s esophagus (BE) and 
duodenal tissues. Figure depicts expression of RALDH1 by real-time-PCR 
performed on a total of: inflamed tissue from reflux esophagitis (RE) (INFL RE, 
n = 9), non-inflamed squamous esophageal epithelium from RE patients (SQ 
RE, n = 9), squamous esophageal epithelium from controls (n = 12), 
squamous esophageal epithelium from BE patients (SQ BE, n = 10), BE 
tissue from BE patients (BE, n = 11), duodenal biopsies from BE patients 
(DUO BE, n = 10), and duodenal biopsies from controls (DUO C, n = 5). The 
Kruskal–Wallis test was used to compare the groups (p < 0.0001). p-values 
from comparing individual groups were obtained by using Mann–Whitney U 
test in case of individual groups and Wilcoxon signed rank test for different 
tissue types from the same patient. Adjustment for multiple comparison was 
conducted by Benjamini–Yekutieli method.
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VCAM-1, a ligand for VLA-4 (very late antigen 4; α4β1) and 
α4β7 (19), is usually upregulated under inflammatory conditions 
(19). However, the expression of VCAM-1 was found to be similar 
in BE and duodenum, and this expression was significantly higher 
or almost reached significance compared to most SQ groups of 
RE/BE patients and controls (Figure 2).
TaBle 3 | Correlations between the relative expression of mRNA in different tissue types.
Barrett’s esophagus (Be) ralDh2 vs. cD11c ralDh2 vs. cD1c ralDh2 vs. rar-β
rsa 0.88 0.7 0.79
p-Value* 0.02 0.08 0.04
inFl reflux esophagitis (re) cD11c vs. cD1a cD11c vs. cD1c cD11c vs. Dc-sign cD1c vs. cD1a cD1c vs. Dc-sign cD1a vs. Dc-sign
rs 0.95 0.92 0.88 0.88 0.95 0.82
p-Value 0.001 0.0028 0.006 0.006 0.001 0.03
Duodenum cD11c vs. cD83 cD83 vs. Dc-sign cD11c vs. cD123
rs 0.74 0.74 0.76
p-Value 0.004 0.004 0.004
Upper section: correlations between RALDH2 with CD11c, CD1c, and RAR-β in BE tissue; middle section: correlations of mRNA expression levels in INFL RE; lower section: 
correlations in duodenal tissue. Correlations were adjusted for multiple testing by Benjamini–Yekutieli method.
aCorrelation coefficient.
*Significant if p < 0.05.
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high expression of FOXP3 mrna in Be 
and its correlation With the expression of 
ralDh2 in Be
FOXP3 (forkhead box P3) is a master regulator in the development 
and function of regulatory T-cells (22). FOXP3 was highly expressed 
in SQ from controls (SQ C). This expression was statistically sig-
nificantly higher compared to inflamed (INFL RE) (p = 0.03) and 
non-inflamed SQ from RE patients (SQ RE) (p = 0.03) (Figure 5B). 
Expression of FOXP3 was also high in BE, which was significantly 
higher compared to duodenal tissue from controls (p  =  0.03) 
(Figure 5B). Further, FOXP3 expression correlated strongly with the 
expression of RALDH2 in BE tissue (rs = 0.82, p = 0.03, Figure 5C).
correlation Between mrna expression of 
ralDh2 and Myeloid Dendritic cell (mDc) 
Markers in Be
To look into which cell type could be responsible for high 
RALDH2 levels in BE, correlation analysis on RALDH2 and 
DC-related mRNA was performed. mRNA RALDH2 expression 
in BE biopsies correlated significantly (p = 0.02) with the mRNA 
expression of CD11c, a mDC marker (Table  3, upper  section) 
(23). In addition, in BE, RALDH2 correlated with CD1c, which 
is also an mDC marker (Table 3). RALDH2 expression levels also 
correlated with RAR-β in BE tissue (p =  0.07), suggesting that 
the increased expression of RALDH2 in BE biopsies is associated 
with a higher expression of RAR-β (Table 3).
mrna expression of Dc-specific Markers 
in squamous esophageal Tissue and 
intestinal Tissue Was associated With 
Distinct T-cell Phenotypes
CD1a is a marker of mDCs and Langerhans cells (24) and is also 
present on immature DCs (25). CD1a+ DCs can enhance cyto-
toxic CD8+-T-cell responses (26). There was a higher expression 
of CD1a mRNA in non-inflamed squamous esophageal tissues 
(SQ RE, SQ C, and SQ BE) (Figure  6A) compared to BE and 
duodenal tissues (Figure 6A). In INFL RE, there was a signifi-
cantly lower expression of CD1a compared to SQ from controls, 
p = 0.006 (Figure 6A). The duodenum of BE patients contained 
high expression of ralDh1 mrna  
in Be Tissue and Duodenal Tissue of Be 
and controls; high expression of rar-β 
mrna in Be
RALDH1 is normally expressed by epithelial cells, including gut 
epithelial cells, which can produce RA in small amounts (20). 
RALDH1 expression was similar in BE and duodenum. RALDH1 
expression in DUO BE was significantly higher compared to 
inflamed (INFL RE) and non-inflamed SQ from RE patients 
and controls (Figure  3). RALDH1 expression in duodenum of 
controls (DUO C) and BE was significantly higher compared to 
INFL RE, SQ RE, and SQ C (Figure 3). Expression of RAR-β in 
SQ of all groups was similar (data not shown). BE was character-
ized by highest RAR-β expression compared to other groups (data 
not shown).
high expression of cYP26a1 mrna in re
CYP26A1, a catabolizing enzyme of RA, was highly expressed 
in inflamed tissue of RE (INFL RE) when compared to SQ of 
BE patients (Figure  4). Expression of CYP26A1 in duodenal 
tissue of controls (DUO C) was significantly higher compared 
to SQ of BE patients (Figure  4). Expression of CYP26A1 was 
similar in BE for both the intestinal tissues of BE and duodenum 
(Figure 4).
high expression of ralDh2 mrna  
in Be Tissue compared to Duodenum  
and sQ
RALDH2 is highly expressed in DCs and plays a crucial role 
in the synthesis of RA in mucosal immune tissues (21). The 
expression of RALDH2 was significantly higher in BE com-
pared to squamous esophageal tissues from RE patients and 
controls (INFL RE, SQ RE, SQ C) (Figure  5A). The expres-
sion of RALDH2 in BE was higher than in duodenum of BE 
patients, but it did not reach significance when corrected for 
multiple testing (Figure  5A). The expression of RALDH2 
in INFL RE and non-inflamed SQ (SQ from RE/BE patients 
and controls) was not-significantly different from each other 
(Figure 5A).
FigUre 6 | Lower expression of CD1a in Barrett’s esophagus (BE) is associated with lower numbers of CD3+CD8+-cells in tissue. Panel (a) depicts expression  
of CD1a by RT-PCR performed on a total of: reflux esophagitis (RE) biopsies from inflamed squamous tissue (INFL RE, n = 9), non-inflamed squamous esophageal 
epithelium from RE patients (SQ RE, n = 9), squamous esophageal epithelium from controls (SQ C, n = 12), squamous esophageal epithelium from BE patients  
(SQ BE, n = 10), BE biopsies (BE, n = 11), duodenal biopsies from BE patients (DUO BE, n = 10), and duodenal biopsies from controls (DUO C, n = 5). CD1a 
expression was corrected for GAPDH, 2−ΔCT ± SEM. Panel (B) represents the percentage of CD3+CD8+-cells from ex vivo cultures of 7 biopsies from inflamed RE 
tissue (INFL RE), 6 non-inflamed squamous esophageal biopsies from RE patients (SQ RE), 39 controls (SQ C), 17 squamous esophageal biopsies from BE patients 
(SQ BE), 19 BE biopsies (BE), 15 duodenal biopsies from BE patients (DUO BE), and 11 duodenal biopsies from controls (DUO C). Each bar represents the mean 
value ± SEM of the percentage of CD3+CD8+-cells in the CD3+ population, determined by flow cytometry. Data were analyzed using the Kruskal–Wallis test (CD1a: 
p < 0.0001, CD3+CD8+: p = 0.0002). p-values from comparing individual groups were obtained by using Mann–Whitney U test in case of individual groups, and 
Wilcoxon signed rank test for different tissue types from the same patient. Adjustment for multiple comparison was conducted by Benjamini–Yekutieli method.  
(c) Dot plot of a CD3+, CD4+, and CD8+ staining on lymphocytes from ex vivo culture of duodenal tissue from BE patient. Cells were gated first on a forward 
sideward scatter plot and for CD3.
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FigUre 7 | Similar CD11c expression in Barrett’s esophagus (BE) and 
duodenal tissues coincides with higher numbers of CD3+CD4+-cells. Panel 
(a) depicts expression of CD11c by real-time-PCR performed on a total of: 
biopsies from inflamed tissue in reflux esophagitis (RE) patients (INFL RE, 
n = 9), non-inflamed squamous esophageal epithelium from RE patients (SQ 
RE, n = 9), squamous esophageal epithelium from controls (SQ C, n = 12), 
squamous esophageal epithelium from BE patients (SQ BE, n = 10), BE 
biopsies (BE, n = 11), duodenal biopsies from BE patients (DUO BE, n = 10), 
and duodenal biopsies from controls (DUO C, n = 5). CD11c expression was 
corrected for GAPDH, 2−ΔCT ± SEM. Panel (B) represent the percentage of 
CD3+CD4+-cells from ex vivo cultures of 7 biopsies from inflamed RE tissue 
(INFL RE), 6 non-inflamed squamous esophageal biopsies from RE patients 
(SQ RE), 39 controls (SQ C), 17 squamous esophageal biopsies from BE 
patients (SQ BE), 19 BE biopsies (BE), 15 duodenal biopsies from BE 
patients (DUO BE), and 11 duodenal biopsies from controls (DUO C). Each 
bar represents the mean value ± SEM of the percentage of CD3+CD4+-cells 
in the CD3+-population, determined by flow cytometry. Data were analyzed 
using the Kruskal–Wallis test (CD11c: p = 0.05, CD3+CD4+: p = 0.0002). 
p-Values from comparing individual groups were obtained by using Mann–
Whitney U test in case of individual groups, and Wilcoxon signed rank test for 
different tissue types from the same patient. Adjustment for multiple 
comparison was conducted by Benjamini–Yekutieli method.
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lower amounts of CD1a mRNA (p = 0.07) compared to BE tissue 
(Figure 6A). The high expression of CD1a corresponded with a 
higher percentage of CD8+-cells in non-inflamed SQ (Figure 6B). 
Figure 6C shows a representative flow cytometry experiment.
CD11c is a classic marker for DCs, specifically for mDCs 
(27). These cells are important in activating CD4+-T-cells (27). 
C11c expression was not different in inflamed (INFL RE) tissue 
compared to non-inflamed SQ from RE/BE patients and controls 
(Figure  7A). While BE tissue was the highest in expression of 
mRNA of CD11c, it was not statistically significant (Figure 7A). 
In BE and duodenal tissue, there were more CD4+-cells found 
compared to non-inflamed SQ (Figure 7B).
correlations Between expression of  
Dc-specific mrna and mrna expression 
of ra Pathway Markers in Biopsies From 
non-inflamed sQ, re Tissue, and 
Duodenum
In non-inflamed SQ from RE, BE patients, and controls, there were 
no strong correlations (rs > 0.7 or rs < −0.7) between DC-specific 
markers at the mRNA level and expression of proteins involved 
in the RA pathway.
In inflamed SQ of RE patients, there were strong correlations 
found in mRNA expression of different DC markers. CD11c 
expression correlated strongly with CD1a (r  =  0.95), CD1c 
(r = 0.92), and DC-sign (DC-specific C-type lectin) (r = 0.95) 
mRNA expression (Table  3, middle section). CD1a mRNA 
expression levels also correlated with those of CD1c and DC-sign 
(Table  3, middle section). In addition, CD1c correlated with 
DC-sign in RE. In the duodenum, CD11c correlated with CD83 
and CD123 (Table  3, lower section). Correlations of mRNA 
expression levels of DC markers in the duodenum are sum-
marized in Table 3, lower section. These correlations were not 
found in BE and SQ (results not shown). There was no correlation 
between RALDH2 and DC-specific mRNA in the duodenum.
Multidimensional analysis by hierarchical 
clustering
To substantiate the coordinated mRNA expression of the tested 
RA-associated genes in BE, SQ, and duodenum, the data were 
analyzed and visualized by hierarchical clustering. Hierarchical 
cluster analysis of all RA-related and DC-specific mRNA expres-
sion levels indicates that BE, duodenum, and SQ were clustered 
separately (Figure 8).
DiscUssiOn
The study by Lind et al. has provided evidence that, in terms of tissue 
response, the immune microenvironment in BE is more like duo-
denal tissue than inflamed esophageal SQ (3). These findings led to 
the hypothesis that the immune response in BE tissue resembled the 
more homeostatic immune response found in duodenal tissue rather 
than an inflammatory response. In our study, this hypothesis was 
tested in more detail by measuring the expression of RA-pathway-
associated genes and DC-specific genes, as RA is important in the 
immune homeostasis in gut tissue (11). In addition, RA has been 
implicated in tissue metaplasia such as seen in BE (10).
We found that mRNA expression of RALDH1, MAdCAM1, 
and VCAM-1 were comparable in BE and duodenal tissue, and 
markedly different in squamous esophageal epithelium. This is in 
line with our hypothesis that BE is characterized by an intestinal 
rather than an inflammatory microenvironment (Figures 1–3) (3).
There are, however, also clear differences between the duode-
num and BE; e.g., the expression of CCL25 is very high in duodenal 
tissue and significantly lower in BE tissue (Figure 1B). Apparently, 
BE tissue is not completely differentiated into a gut-like environ-
ment, possibly explaining the partial phenotype. This conclusion is 
further supported by analysis of RAR-β expression, which is seen 
FigUre 8 | Hierarchical clustering of real-time-PCR data. The expression of all different mRNAs of all groups (BE, BE tissue; SQBE, squamous esophageal tissue 
from BE patients; DUOBE, duodenal tissue from BE patients; RE, inflamed esophageal tissue from RE patients; SQRE, non-inflamed squamous esophageal tissue 
from RE patients; SQC, esophageal tissue from controls; DUOC, duodenal tissue from controls) were clustered.
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than a pro-inflammatory microenvironment. This is contrary to 
the view that BE is solely an inflammation-driven phenomenon 
and points to an induction of anti-inflammatory homeostatic 
responses by aberrant BE tissue in the esophagus (3, 33).
By analyzing DC markers in the duodenum, a correlation was 
found between the expression CD11c and CD83, as well as between 
CD83 and DC-sign. These correlations were not seen in BE, sug-
gesting the presence of different DC-phenotypes in the duodenum 
and BE (Table 3) (34). In BE, CD11c correlated with CD1c and 
RALDH2, suggesting mDCs, which are rich in RALDH2; whereas 
in the duodenum, more activated mature DCs were found (34).
No similarities were found between INFL RE and BE. In RE, 
there were strong correlations between CD1c, CD1a and CD11c, 
and DC-sign, which implies the presence of a population of 
monocyte-derived DCs, typically found at sites of inflammation 
(Table 3, middle section) (35–37). In BE, these correlations were 
not present, again suggesting that BE was not associated with an 
ongoing inflammation such as found in inflamed tissue of RE. 
Expression of dendritic markers varied strongly per patient as 
seen in Figures 6 and 7. Yet, correlations between the dendritic 
markers in RE and duodenal had shown high correlation strength 
(r = 0.95), even after correction for multiple comparison.
With respect to DCs (mRNA), our data are in line with our 
previously published research concerning T-cell phenotypes (3). 
High CD1a expression in non-inflamed SQ was associated with a 
high percentage of CD8+-cells. The CD1a+-DCs are important in 
activation of these cytotoxic T-cells (Figure 6) (26). High CD11c 
expression in BE correlated with a higher percentage of CD4+-T-
cells. CD11c+-DCs are important for the activation of CD4+-T-cells 
(Figure 7) (27). This implies that different DC-subsets are seen in 
BE tissue and squamous esophageal tissue, which might lead to 
differential activation of distinctive T-cell phenotypes.
To visualize the effect of RA, which is produced mainly by DCs 
in vivo, we performed in vitro experiments (32). By adding RA 
as an in vivo readout of RA activity (28). RAR-β mRNA expression 
is high in BE; this correlates with RALDH2 expression, supporting 
the concept that RALDH2 activity is associated with a high RA 
production in the tissue (Figure 5; Table 3). CYP26A1, an enzyme 
that catabolyzes RA, was found to be lower in SQ BE (significantly, 
p < 0.0005) and tended to be lower BE (not-significantly), com-
pared to inflamed tissue of RE (Figure 4). CYP26A1 is elevated in 
Barrett’s adenocarcinoma, and can cause proliferation of epithelial 
cells when overexpressed (29). Zolfaghari et al. found that inflam-
mation can influence RA-metabolism by abrogating the induction 
of CYP26A1 by RA in the liver. However, we found the opposite: 
induction of CYP26A1 was highest in inflamed tissue in RE (30). 
Apparently, the RA-metabolism in esophageal tissue is distinct 
from systemic RA-metabolism. Yet, lower mRNA expression of 
RALDH1-2 and RAR-β in SQ, as found in our study, is in line with 
relatively higher CYP26A1 expression.
Barrett’s esophagus was characterized by the highest expres-
sion of RALDH2 (Figure 5A). RALDH2 is highly expressed in 
DCs, and therefore, the mRNA expression of DC-specific mark-
ers was measured and compared with the expression of RALDH2 
in the same samples. The correlations between the expression of 
RALDH2 and CD11c and CD1c implicated that mDCs were 
associated with high RALDH2 expression (Table 3) and high RA 
production, as found by Chang et al. (7).
This conclusion was further supported by the findings that 
mRNA for FOXP3 was markedly enhanced in BE (Figure  5B) 
and that RALDH2 expression correlated strongly with FOXP3 
in this tissue (Figure 5C). The FOXP3 gene in regulatory T-cells 
has been described to be induced by RA (31, 32). The correlation 
between RALDH2 and FOXP3 in BE tissue supported the hypoth-
esis that the higher expression of FOXP3 was the result of higher 
RALDH2 expression, which has also been shown in gut tissue (21). 
Interestingly, the high expression of FOXP3 supports the hypothesis 
of an anti-inflammatory, gut-like microenvironment in BE rather 
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to the PBMCs, we showed that α4 and β7 were upregulated on 
T-cells, validating the finding that RA induced intestinal integrins 
on lymphocytes (Figure S2 in Supplementary Material).
The data mentioned above support the hypothesis that the 
immune homeostasis in BE tissue resembles duodenal tissue more 
than esophageal tissue. However, most of the data were based on the 
analysis of single markers. To strengthen this hypothesis, all of the 
markers that were used in this study were evaluated using cluster 
analysis (Figure 8). Hierarchical clustering of expression of genes 
showed that tissues of BE, duodenum, and squamous esophageal 
tissues are clustered as three different groups (Figure 8). This is in 
line with our hypothesis that SQ tissue and BE are distinct tissue 
types. Furthermore, we have shown that BE and duodenum share 
common characteristics, and these are found to be associated with 
high activity of the RA-pathway (7, 29). These data also provide a 
mechanism for RA-regulated homeostatic homing of immune cells 
to BE tissue. Unfortunately, as biopsies were small and we were 
restricted in the number of biopsies we could obtain, it was not 
possible to perform experiments where we could see which cells 
were responsible for differential gene expression.
In conclusion, the immune microenvironment of BE shares 
many similarities with that of duodenal tissue, but also has its own 
special features. This suggests (3) that BE is characterized by the 
presence of tolerogenic RALDH2+DCs and regulatory T-cells, 
pointing to a non-inflammatory environment in BE tissue. Thus, 
our findings suggest that aberrant RA-mediated responses, rather 
than inflammation, are important in pathogenesis of BE. Therefore, 
application of anti-inflammatory drugs as treatment for BE remains 
questionable, as there are no clear signs of inflammation in BE.
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